O

OncoResponse Inc.

29 employees

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

Basic info

Industry

research

Sectors

Biotechnology
Health Care
Therapeutics
Biopharma

Date founded

2016

Funding rounds raised

Total raised

$41M

from 29 investors over 29 rounds

O

OncoResponse Inc. raised $14M on May 18, 2023

Investors: RiverVest Venture Partners, INTERVEST-Mortgage Investment Co., 3B Future Health Fund, Canaan, Takeda UK Limited, ARCH Venture Partners and Bering Capital

O

OncoResponse Inc. raised $13M on May 18, 2023

Investors: Cancer Prevention and Research Institute of Texas

O

OncoResponse Inc. raised $41M on March 31, 2021

Investors: 3B Future Health Fund, RiverVest Venture Partners, Redmile Group, ARCH Venture Partners, Magnetar Capital, Bering Capital, Qatar Investment Authority and Canaan

O

OncoResponse Inc. raised $40M on September 11, 2018

Investors: 3B Future Health Fund, RiverVest Venture Partners, ARCH Venture Partners, Redmile Group, Rice University, Canaan and Qatar Investment Authority

O

OncoResponse Inc. raised $7M on October 10, 2016

Investors: 3B Future Health Fund and GreatPoint Ventures

O

OncoResponse Inc. raised $13M on May 7, 2016

Investors: Rice University, -, ARCH Venture Partners and Canaan

FAQ